텍사스의 궤양성 대장염 임상 시험
궤양성 대장염 관련 연구 30개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.
텍사스의 도시
- Houston연구 14개
- Tyler연구 13개
- San Antonio연구 13개
- Lubbock연구 9개
- Round Rock연구 8개
- Lewisville연구 8개
- Garland연구 8개
- Fort Worth연구 8개
- League City연구 7개
- Dallas연구 6개
- The Woodlands연구 6개
- Arlington연구 3개
공식 연구 텍스트(영어)
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-024, Garland
- Site US-009, Georgetown
- Site US-030, Houston
- 외 4개
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07845487Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT04751396Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- 외 2개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT03816345A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Texas Digestive Disease Consultants, Cedar Park
- Baylor College of Medicine, Houston
- Tyler Research Institute, LLC, Tyler
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06636656Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290), Garland
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
- 외 3개
피험자 모집 중3상
전 연령 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06651281LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Fort Worth, Fort Worth
- GI Alliance - Garland, Garland
- Integrity Advanced Therapeutics, Houston
- 외 4개
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07415044A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- One of a Kind Clinical Research Center - Kingwood, Kingwood
- Southern Star Research Institute, San Antonio
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07483073Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Texas Digestive Disease Consultants - Cedar Park, Cedar Park
- GI Alliance - Dallas - Gaston Avenue, Dallas
- GI Alliance - Fort Worth, Fort Worth
- 외 5개
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07186101A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cook Childrens Medical Center, Fort Worth
피험자 모집 중3상
3세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06663332A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Southern Star Research Institute, LLC, San Antonio
- Tyler Research Institute, LLC, Tyler
- GIA Webster, Webster
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07577856A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- BAMC, Houston
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT04372108Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Cedar Park
- Xencor Investigative Site, Denton
- Xencor Investigative Site, Garland
- 외 8개
피험자 모집 중1/2상건강한 지원자 환영
18세 ~ 75세 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT06619990A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- The Clinical Trials Network CTNX LLC, El Paso
- Amel Med LLC, Georgetown
- Kelsey Research Foundation, Houston
- 외 7개
피험자 모집 중4상
18세 ~ 80세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Novel Research - Bellaire /ID# 280925, Bellaire
- Gi Alliance - Texas Digestive Disease Consultants - Fort Worth /ID# 283977, Fort Worth
- GI Alliance -Garland /ID# 284253, Garland
- 외 10개
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07697456A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- ACT-Midwest G1, Abilene
- Cook Children's Health Care System-Dodson Specialty Clinics, Fort Worth
- Cook Children's Medical Center, Fort Worth
피험자 모집 중2상
12세 ~ 17세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT05287126A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 013, Cedar Park
- Site 005, Garland
- Site 002, San Antonio
- 외 2개
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07012395A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- University of Texas - Southwestern Medical Center /ID# 271835, Dallas
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07071519An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Houston Endoscopy & Research Center, Houston
- BI Research Center, Houston
- Brooke Army Medical center, San Antonio
- 외 2개
피험자 모집 중관찰 연구
18세 ~ 64세 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06398626An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Inquest Clinical Research - Site Number: 8400144, Baytown
- The University of Texas Southwestern Medical Center - Site Number: 8400098, Dallas
- Valley Institute of Research - Site Number: 8400004, Harlingen
- 외 7개
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07184996Confirmatory Clinical Study in Active Ulcerative Colitis
- Southern Star Research Institute, San Antonio
피험자 모집 중2상
16세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT07296315A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Local Institution - 0103, Fort Worth
- Texas Children's Hospital, Houston
피험자 모집 중2/3상
2세 ~ 17세 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT05076175A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- One of a Kind Clinical Research Center TX, LLC-Site Number: 8400125, Kingwood
- GI Alliance - Lubbock - Site Number: 8400092, Lubbock
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
- 외 2개
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 10. 16. 업데이트됨 · NCT07185009A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Cook Children's Medical Center, Fort Worth
피험자 모집 중3상
2세 ~ 19세 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT04844606Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Texas Southwestern, Dallas
- Baylor College of Medicine, Houston
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT05230173BOOM-IBD2 Pivotal Clinical Trial
- Amarillo Premier Research (Objective Health), Amarillo
- Digestive Research of Central Texas (Objective Health), Waco
피험자 모집 중
18세 ~ 85세 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT06571669A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- Tyler Research Institute, LLC, Tyler
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 5. 22. 업데이트됨 · NCT06764615A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Texas Children's Hospital - Baylor - PIN, Houston
피험자 모집 중3상
2세 이상 · 모든 성별 · 2026. 5. 7. 업데이트됨 · NCT05442567A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Dallas
- Mirador Therapeutics Selected Site, Garland
- Mirador Therapeutics Selected Site, Georgetown
- 외 5개
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 3. 12. 업데이트됨 · NCT07113522Registry and Biorepository for IBD in Central Texas
- Dell Medical School, UT Austin, Austin
피험자 모집 중관찰 연구
18세 ~ 100세 · 모든 성별 · 2021. 5. 18. 업데이트됨 · NCT04617184ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.